Adoption and diffusion of evidence-based addiction medications in substance abuse treatment

Health Services Research

Volumn 49, Issue 1, 2014, Pages 127-152

  Heinrich, Carolyn J ^a   Cummings, Grant R ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Wisconsin Legislative Audit Bureau   (United States)

Author keywords

diffusion; policy; Substance abuse treatment

Indexed keywords

BUPRENORPHINE; DISULFIRAM; NALTREXONE;

ADDICTION; ADOPTION; ALCOHOL POLICY INFORMATION SYSTEM; ARTICLE; CENTERS FOR MEDICARE AND MEDICAID SERVICES; HEALTH SURVEY; HUMAN; KAISER FAMILY FOUNDATION; MEDICAID; NATIONAL SURVEY OF SUBSTANCE ABUSE TREATMENT SERVICES; SUBSTANCE ABUSE; SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION;

DIFFUSION; POLICY; SUBSTANCE ABUSE TREATMENT;

ALCOHOL DETERRENTS; BUPRENORPHINE; DIFFUSION OF INNOVATION; DISULFIRAM; EVIDENCE-BASED MEDICINE; HEALTH SERVICES RESEARCH; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84892809984     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12093     Document Type: Article

References (37)

1. Backer, T. E., 1995. " Assessing and Enhancing Readiness for Change: Implications for Technology Transfer." In Reviewing the Behavioral Science Knowledge Base on Technology Transfer (NIDA Research Monograph 155, NIH Publication No. 95-4035), edited by, T. E. Backer, S. L. David, and, G. Soucy, pp. 169-85. Rockville, MD: National Institute on Drug Abuse.
2. Berry, F. S., and, W. D. Berry,. 1990. " State Lottery Adoptions as Policy Innovations: An Event History Analysis." American Political Science Review 84: 395-415.
3. Berry, F. S., and, W. D. Berry,. 1992. " Tax Innovation in the States: Capitalizing on Political Opportunity." American Journal of Political Science 36: 715-42.
4. Borins, S., 1998. Innovating with Integrity: How Local Heroes Are Transforming American Government. Washington, DC: Georgetown University Press.
5. Brown, B. S., and, P. M. Flynn,. 2002. " The Federal Role in Drug Abuse Technology Transfer: A History and Perspective." Journal of Substance Abuse Treatment 22 (4): 245-57.
6. Damanpour, F., 1991. " Organizational Innovation: A Meta-Analysis of Effects of Determinants and Moderators." Academy of Management Journal 34: 555-90.
7. Drake, R., S. M. Essock, A. Shaner, K. B. Carey, K. Minkoff, L. Kola, D. Lynde, F. C. Osher, R. E. Clark, and, L. Richards,. 2001. " Implementing Dual Diagnosis Services for Clients with Severe Mental Illness." Psychiatric Services 52: 469-76.
8. Ducharme, L. J., H. K. Knudsen, P. M. Roman, and, J. A. Johnson,. 2007. " Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network." Journal of Substance Abuse Treatment 32 (4): 321-9.
9. Friedmann, P. D., J. A. Alexander, and, T. A. D'Aunno,. 1999. " Organizational Correlates of Access to Primary Care and Mental Health Services in Drug Abuse Treatment Units." Journal of Substance Abuse Treatment 16: 71-80.
10. Fuller, B. E., T. Rieckmann, D. McCarty, K. W. Smith, and, H. Levine,. 2005. " Adoption of Naltrexone to Treat Alcohol Dependence." Journal of Substance Abuse Treatment 28 (3): 273-80.
11. Goldman, H. H., V. Ganju, R. Drake, P. Gorman, M. Hogan, P. S. Hyde, and, O. Morgan,. 2001. " Policy Implications for Implementing Evidence-Based Practices." Psychiatric Services 52: 1591-7.
12. Harris, K. M., and, C. Thomas,. 2004. " Naltrexone and Pharmacy Benefit Management." Journal of Addictive Diseases 23 (4): 11-29.
13. Heinrich, C. J., and, E. Fournier,. 2004. " Dimensions of Publicness and Performance in Substance Abuse Treatment Organizations." Journal of Policy Analysis and Management 23 (1): 49-70.
14. Heinrich, C. J., and, C. J. Hill,. 2008. " The Role of State Policies in the Adoption of Naltrexone for Substance Abuse Treatment." Health Services Research 43 (3): 951-70.
15. Heinrich, C. J., and, L. E. Lynn,. 2002. " Improving the Organization, Management, and Outcomes of Substance Abuse Treatment Programs." The American Journal of Drug and Alcohol Abuse 28 (4): 601-22.
16. Jensen, J. L., 2003. " Policy Diffusion through Institutional Legitimation: State Lotteries." Journal of Public Administration Research and Theory 13 (4): 521-42.
17. Knudsen, H. K., L. J. Ducharme, and, P. M. Roman,. 2006. " Early Adoption of Buprenorphine in Substance Abuse Treatment Centers: Data from the Private and Public Sectors." Journal of Substance Abuse Treatment 30 (4): 363-73.
18. Knudsen, H. K., and, P. M. Roman,. 2004. " Modeling the Use of Innovations in Private Treatment Organizations: The Role of Absorptive Capacity." Journal of Substance Abuse Treatment 26: 51-9.
19. Knudsen, H. K., and, P. M. Roman,. 2012. Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders. Journal of Addiction Medicine 6 (4): 280-6 [accessed on August 23, 2012]. Available at http://ctndisseminationlibrary.org/display/870.htm (in press).
20. Knudsen, H. K., L. J. Ducharme, P. M. Roman, and, T. J. Link,. 2005a. " Buprenorphine Diffusion: The Attitudes of Substance Abuse Treatment Counselors." Journal of Substance Abuse Treatment 29: 95-106.
21. Knudsen, H. K., P. M. Roman, L. D. Ducharme, and, A. J. Johnson,. 2005b. " Organizational Predictors of Pharmacological Innovation Adoption: The Case of Disulfiram." Journal of Drug Issues 35: 553-68.
22. Kovas, A., B. McFarland, D. McCarty, J. Boverman, and, J. Thayer,. 2007. " Buprenorphine for Acute Heroin Detoxification: Diffusion of Research into Practice." Journal of Substance Abuse Treatment 32 (2): 199-206.
23. Mooney, C. Z., 2001. " Modeling Regional Effects on State Policy Diffusion." Political Research Quarterly 54 (1): 103-24.
24. Oser, C. B., and, R. M. Roman,. 2007. " Organizational-Level Predictors of Adoption across Time: Naltrexone in Private Substance-use Disorders Treatment Centers." Journal of Studies on Alcohol 68 (6): 852-61.
25. Rieckmann, T., A. E. Kovas, and, B. A. Rutkowski,. 2010. " Adoption of Medications in Substance Abuse Treatment: Priorities and Strategies of Single State Authorities." Journal of Psychoactive Drugs 42 (suppl 6): 227-38.
26. Rogers, E. M., 2003. Diffusion of Innovations, 5th edition. New York: Free Press.
27. Roman, P. M., L. J. Ducharme, and, H. K. Knudsen,. 2006. " Patterns of Organization and Management in Private and Public Substance Abuse Treatment Programs." Journal of Substance Abuse Treatment 31 (3): 235-43.
28. Roman, P. M., and, J. A. Johnson,. 2002. " Adoption and Implementation of New Technologies in Substance Abuse Treatment." Journal of Substance Abuse Treatment 22: 211-8.
29. Schmidt, L., and, C. Weisner,. 1993. " Developments in Alcoholism Treatment." In Recent Developments in Alcoholism, Volume 11: Ten Years of Progress, edited by, M. Galanter, pp. 369-96. New York: Plenum Press.
30. Schmidt, L. A., T. Rieckmann, A. Abraham, T. Molfenter, V. Capoccia, P. Roman, D. H. Gustafson, and, D. McCarty,. 2012. " Advancing Recovery: Implementing Evidence-Based Treatment for Substance Use Disorders at the Systems Level." Journal of Studies on Alcohol and Drugs 73 (3): 413-22.
31. Simpson, D. D., 2002. " A Conceptual Framework for Transferring Research to Practice." Journal of Substance Abuse Treatment 22: 171-82.
32. Simpson, D. D., G. W. Joe, and, G. A. Rowan-Szal,. 2007. " Linking the Elements of Change: Program and Client Responses to Innovation." Journal of Substance Abuse Treatment 33 (2): 201-9.
33. Thomas, C. P., and, D. McCarty,. 2004. " Adoption of Drug Abuse Treatment Technology in Specialty and Primary Care Settings." In New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions, edited by, H. J. Harwood, and, T. G. Myers, pp. 140-72. Washington, DC: The National Academies Press.
34. Walker, J., 1969. " The Diffusion of Innovations among the American States." American Political Science Review 63: 880-99.
35. Wheeler, J. R. C., and, T. A. Nahra,. 2000. " Private and Public Ownership in Behavioral Health Care: Do We Have a Two-Tiered System? " Administration and Policy in Mental Health 27 (4): 197-209.
36. Yi, H., C. M. Chen, Y. Yoon, and, M. E. Hilton,. 2007. Effect of Health Insurance Parity Laws on Healthcare Coverage for Alcohol-Related Hospitalizations in the United States. Working paper. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health.
37. Zarkin, G. A., D. N. Galinis, M. T. French, D. L. Fountain, P. W. Ingram, and, J. A. Guyett,. 1995. " Financing Strategies for Drug Abuse Treatment Programs." Journal of Substance Abuse Treatment 12: 385-99.